About: http://webisa.webdatacommons.org/369872297

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Alnylam retains full rights to use this IP for advancing RNAi therapeutic products to the market, including the rights to sublicense IP on a product-by-product basis.
http://www.w3.org/ns/prov#wasQuotedFrom	ipwatchdog.com